Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 5642-5649

  Sampson, Timothy R ^a,b   Liu, Xiang ^a,b   Schroeder, Max R ^a   Kraft, Colleen S ^a,b   Burd, Eileen M ^a,b   Weiss, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CLAVULANATE POTASSIUM PLUS TICARCILLIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; HYDROXYL RADICAL; KANAMYCIN; LEVOFLOXACIN; MEROPENEM; POLYMYXIN B; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; CROSS INFECTION; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FREE RADICAL SCAVENGERS; HUMANS; HYDROXYL RADICAL; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; POLYMYXIN B;

EID: 84868028125     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00756-12     Document Type: Article

References (50)

1. Adams MD, et al. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53:3628-3634.
2. Arroyo LA, et al. 2011. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob. Agents Chemother. 55:3743-3751.
3. Baang JH, et al. 2012. Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital. Am. J. Infect. Control 40:134-137.
4. Beceiro A, et al. 2011. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55:3370-3379.
5. Bergogne-Berezin E. 2001. The increasing role of Acinetobacter species as nosocomial pathogens. Curr. Infect. Dis. Rep. 3:440-444.
6. Bergogne-Berezin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
7. Cotroneo N, Harris R, Perlmutter N, Beveridge T, Silverman JA. 2008. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob. Agents Chemother. 52:2223-2225.
8. David HL, Rastogi N. 1985. Antibacterial action of colistin (polymyxin E) against Mycobacterium aurum. Antimicrob. Agents Chemother. 27:701-707.
9. Davies BW, et al. 2009. Hydroxyurea induces hydroxyl radical-mediated cell death in Escherichia coli. Mol. Cell 36:845-860.
10. Dixon RA, Chopra I. 1986. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J. Antimicrob. Chemother. 18:557-563.
11. Durante-Mangoni E, Zarrilli R. 2011. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 6:407-422.
12. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. 2007. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 3:91.
13. Eisenstein BI. 2008. Treatment of staphylococcal infections with cyclic lipopeptides. Clin. Microbiol. Infect. 14(Suppl 2):10-16.
14. Henry R, et al. 2012. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine. Antimicrob. Agents Chemother. 56:59-69.
15. Hong KB, et al. 2012. Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii infection in a pediatric intensive care unit. Pediatr. Infect. Dis. J. 31:685-690.
16. Imlay JA, Chin SM, Linn S. 1988. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240: 640-642.
17. Imlay JA, Linn S. 1988. DNA damage and oxygen radical toxicity. Science 240:1302-1309.
18. Jimenez-Mejias ME, et al. 1997. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clin. Infect. Dis. 24:932-935.
19. Jones CL, et al. 2012. Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76:383-404.
20. Kashyap DR, et al. 2011. Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems. Nat. Med. 17:676-683.
21. Klemperer RM, Gilbert P, Meier AM, Cozens RM, Brown MR. 1979. Influence of suspending media upon the susceptibility of Pseudomonas aeruginosa NCTC 6750 and its spheroplasts to polymyxin B. Antimicrob. Agents Chemother. 15:147-151.
22. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810.
23. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. 2008. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135:679-690.
24. Lee BY, McGlone SM, Doi Y, Bailey RR, Harrison LH. 2010. Economic impact of Acinetobacter baumannii infection in the intensive care unit. Infect. Control Hosp. Epidemiol. 31:1087-1089.
25. Li J, et al. 2006. Colistin: the re-emerging antibiotic for multidrugresistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
26. Lim LM, et al. 2010. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 30:1279-1291.
27. 2-induced killing. Infect. Immun. 79:1218 - 1224.
28. Mai J, et al. 2011. A novel target-specific, salt-resistant antimicrobial peptide against the cariogenic pathogen Streptococcus mutans. Antimicrob. Agents Chemother. 55:5205-5213.
29. Manchanda V, Sanchaita S, Singh N. 2010. Multidrug resistant acinetobacter. J. Global Infect. Dis. 2:291-304.
30. Moffatt JH, et al. 2010. Colistin resistance in Acinetobacter baumannii is mediated bycomplete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54:4971-4977.
31. Mogi T, et al. 2009. Polymyxin B identified as an inhibitor of alternative NADH dehydrogenase and malate: quinone oxidoreductase from the Gram-positive bacterium Mycobacterium smegmatis. J. Biochem. 146: 491-499.
32. Morrison DC, Jacobs DM. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 13:813-818.
33. Park YK, et al. 2009. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea. Emerg. Infect. Dis. 15: 1325-1327.
34. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
35. Repine JE, Fox RB, Berger EM. 1981. Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical. J. Biol. Chem. 256:7094-7096.
36. Sengstock DM, et al. 2010. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin. Infect. Dis. 50:1611-1616.
37. Sikora AE, Beyhan S, Bagdasarian M, Yildiz FH, Sandkvist M. 2009. Cell envelope perturbation induces oxidative stress and changes in iron homeostasis in Vibrio cholerae. J. Bacteriol. 191:5398-5408.
38. Soon RL, et al. 2011. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment. J. Antimicrob. Chemother. 66:126-133.
39. Sutter DE, et al. 2011. High incidence of multidrug-resistant gramnegative bacteria recovered from Afghan patients at a deployed US military hospital. Infect. Control Hosp. Epidemiol. 32:854-860.
40. Terce F, Gillois M, Laneelle G. 1979. Respiratory chain inhibition by polymyxin b in a gram-positive bacterium (Micrococcus luteus). FEMS Microbiol. Lett. 6:357-360.
41. Tien HC, et al. 2007. Multidrug resistant Acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect. Dis. 7:95. doi: 10.1186/1471-2334-7-95.
42. Tochikubo K, Yasuda Y, Kozuka S. 1986. Decreased particulate NADH oxidase activity in Bacillus subtilis spores after polymyxin B treatment. J. Gen. Microbiol. 132:277-287.
43. Villers D, et al. 1998. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann. Intern. Med. 129:182-189.
44. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. 2010. Role of hospital surfaces in the transmission of emerging health careassociated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am. J. Infect. Control. 38:S25-S33.
45. Webster C, Towner KJ, Humphreys H. 2000. Survival of Acinetobacter on three clinically related inanimate surfaces. Infect. Control Hosp. Epidemiol. 21:246.
46. Wendt C, Dietze B, Dietz E, Ruden H. 1997. Survival of Acinetobacter baumannii on dry surfaces. J. Clin. Microbiol. 35:1394-1397.
47. Wolff M, et al. 1997. The changing epidemiology of severe infections in the ICU. Clin. Microbiol. Infect. 3:s36-s47.
48. Wright GD. 2007. On the road to bacterial cell death. Cell 130:781-783.
49. Yeom J, Imlay JA, Park W. 2010. Iron homeostasis affects antibiotic-mediated cell death in Pseudomonas species. J. Biol. Chem. 285:22689-22695.
50. Zavascki AP, Goldani LZ, Li J, Nation RL. 2007. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J. Antimicrob. Chemother. 60:1206-1215.